Nahid Bhadelia

Nahid Bhadelia is an American infectious-diseases physician, founding director of Center for Emerging Infectious Diseases Policy and Research (CEID), an associate director at National Emerging Infectious Diseases Laboratories (NEIDL) at Boston University, and an associate professor at the Boston University School of Medicine. She currently serves as the Senior Policy Advisor for Global COVID-19 Response on the White House COVID-19 Response Team. Bhadelia attended Tufts University, where she received her Bachelor of Science degree. She continued her education at Tufts University School of Medicine, where she received her Doctor of Medicine. While in medical school, she served as an HIV/AIDS counselor and clinic coordinator for a student-run clinic that serves underserved populations in Malden, Massachusetts. Bhadelia also holds a Master's degree in international affairs from the Fletcher School of Law and Diplomacy, specializing in health security with a focus on pandemic response. In 1999, Bhadelia worked as the Director of National Outreach for Oxfam America, working on projects related to civic engagement of young Americans in voting and policy change issues. In 2002, she worked with Massachusetts Campus Compact on a project funded by Pew Charitable trusts to promote voting among college students. She completed her medical training in New York City at Mount Sinai Hospital and Columbia Presbyterian Hospital. In 2011, Bhadelia began working at Boston Medical Center and Boston University School of Medicine. With a specialization in infection control and emerging pathogens, Bhadelia served as the medical director of the Special Pathogens Unit. She was also the Director of Infection Control at the National Emerging Infectious Diseases Laboratories, a biosafety level 4 laboratory, which is one of six such programs for studying deadly viruses in the United States. During her career, she has worked on assessing the healthcare response to the 2009 flu pandemic that resulted from Influenza A virus subtype H1N1, the 2013-2016 Ebola virus epidemic, and the 2020 COVID-19 pandemic.